These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

525 related items for PubMed ID: 32438662

  • 1. Concerted EP2 and EP4 Receptor Signaling Stimulates Autocrine Prostaglandin E2 Activation in Human Podocytes.
    Mangelsen E, Rothe M, Schulz A, Kourpa A, Panáková D, Kreutz R, Bolbrinker J.
    Cells; 2020 May 19; 9(5):. PubMed ID: 32438662
    [Abstract] [Full Text] [Related]

  • 2. Cyclooxygenase-2, prostaglandin E2, and prostanoid receptor EP2 in fluid flow shear stress-mediated injury in the solitary kidney.
    Srivastava T, Alon US, Cudmore PA, Tarakji B, Kats A, Garola RE, Duncan RS, McCarthy ET, Sharma R, Johnson ML, Bonewald LF, El-Meanawy A, Savin VJ, Sharma M.
    Am J Physiol Renal Physiol; 2014 Dec 15; 307(12):F1323-33. PubMed ID: 25234310
    [Abstract] [Full Text] [Related]

  • 3. Fluid flow shear stress upregulates prostanoid receptor EP2 but not EP4 in murine podocytes.
    Srivastava T, McCarthy ET, Sharma R, Kats A, Carlton CG, Alon US, Cudmore PA, El-Meanawy A, Sharma M.
    Prostaglandins Other Lipid Mediat; 2013 Dec 15; 104-105():49-57. PubMed ID: 23262148
    [Abstract] [Full Text] [Related]

  • 4. Prostanoid receptors in hyperfiltration-mediated glomerular injury: Novel agonists and antagonists reveal opposing roles for EP2 and EP4 receptors.
    Srivastava T, Garola RE, Zhou J, Boinpelly VC, Priya L, Ali MF, Rezaiekhaligh MH, Heruth DP, Novak J, Alon US, Joshi T, Jiang Y, McCarthy ET, Savin VJ, Johnson ML, Sharma R, Sharma M.
    FASEB J; 2022 Oct 15; 36(10):e22559. PubMed ID: 36125047
    [Abstract] [Full Text] [Related]

  • 5. Studies in Zebrafish and Rat Models Support Dual Blockade of EP2 and EP4 (Prostaglandin E2 Receptors Type 2 and 4) for Renoprotection in Glomerular Hyperfiltration and Albuminuria.
    Kourpa A, Schulz A, Mangelsen E, Kaiser-Graf D, Koppers N, Stoll M, Rothe M, Bader M, Purfürst B, Kunz S, Gladytz T, Niendorf T, Bachmann S, Mutig K, Bolbrinker J, Panáková D, Kreutz R.
    Hypertension; 2023 Apr 15; 80(4):771-782. PubMed ID: 36715011
    [Abstract] [Full Text] [Related]

  • 6. T cell-intrinsic prostaglandin E2-EP2/EP4 signaling is critical in pathogenic TH17 cell-driven inflammation.
    Lee J, Aoki T, Thumkeo D, Siriwach R, Yao C, Narumiya S.
    J Allergy Clin Immunol; 2019 Feb 15; 143(2):631-643. PubMed ID: 29935220
    [Abstract] [Full Text] [Related]

  • 7. Differential expression of E-type prostanoid receptors 2 and 4 in microglia stimulated with lipopolysaccharide.
    Bonfill-Teixidor E, Otxoa-de-Amezaga A, Font-Nieves M, Sans-Fons MG, Planas AM.
    J Neuroinflammation; 2017 Jan 05; 14(1):3. PubMed ID: 28086956
    [Abstract] [Full Text] [Related]

  • 8. Mechanotransduction signaling in podocytes from fluid flow shear stress.
    Srivastava T, Dai H, Heruth DP, Alon US, Garola RE, Zhou J, Duncan RS, El-Meanawy A, McCarthy ET, Sharma R, Johnson ML, Savin VJ, Sharma M.
    Am J Physiol Renal Physiol; 2018 Jan 01; 314(1):F22-F34. PubMed ID: 28877882
    [Abstract] [Full Text] [Related]

  • 9. Prostaglandin E2-Induced COX-2 Expressions via EP2 and EP4 Signaling Pathways in Human LoVo Colon Cancer Cells.
    Hsu HH, Lin YM, Shen CY, Shibu MA, Li SY, Chang SH, Lin CC, Chen RJ, Viswanadha VP, Shih HN, Huang CY.
    Int J Mol Sci; 2017 May 25; 18(6):. PubMed ID: 28587064
    [Abstract] [Full Text] [Related]

  • 10. Role of EP2 and EP4 receptors in airway microvascular leak induced by prostaglandin E2.
    Jones VC, Birrell MA, Maher SA, Griffiths M, Grace M, O'Donnell VB, Clark SR, Belvisi MG.
    Br J Pharmacol; 2016 Mar 25; 173(6):992-1004. PubMed ID: 26639895
    [Abstract] [Full Text] [Related]

  • 11. Activation of prostaglandin EP4 receptor attenuates the induction of cyclooxygenase-2 expression by EP2 receptor activation in human amnion fibroblasts: implications for parturition.
    Lu JW, Wang WS, Zhou Q, Gan XW, Myatt L, Sun K.
    FASEB J; 2019 Jul 25; 33(7):8148-8160. PubMed ID: 30917001
    [Abstract] [Full Text] [Related]

  • 12. 15-Keto-PGE2 acts as a biased/partial agonist to terminate PGE2-evoked signaling.
    Endo S, Suganami A, Fukushima K, Senoo K, Araki Y, Regan JW, Mashimo M, Tamura Y, Fujino H.
    J Biol Chem; 2020 Sep 18; 295(38):13338-13352. PubMed ID: 32727851
    [Abstract] [Full Text] [Related]

  • 13. Characterization of the EP receptor subtype that mediates the inhibitory effects of prostaglandin E2 on IgE-dependent secretion from human lung mast cells.
    Kay LJ, Gilbert M, Pullen N, Skerratt S, Farrington J, Seward EP, Peachell PT.
    Clin Exp Allergy; 2013 Jul 18; 43(7):741-51. PubMed ID: 23786281
    [Abstract] [Full Text] [Related]

  • 14. Upregulated proteoglycan-related signaling pathways in fluid flow shear stress-treated podocytes.
    Srivastava T, Joshi T, Jiang Y, Heruth DP, Rezaiekhaligh MH, Novak J, Staggs VS, Alon US, Garola RE, El-Meanawy A, McCarthy ET, Zhou J, Boinpelly VC, Sharma R, Savin VJ, Sharma M.
    Am J Physiol Renal Physiol; 2020 Aug 01; 319(2):F312-F322. PubMed ID: 32628542
    [Abstract] [Full Text] [Related]

  • 15. Intact prostaglandin signaling through EP2 and EP4 receptors in stromal progenitor cells is required for normal development of the renal cortex in mice.
    Fuchs MAA, Schrankl J, Leupold C, Wagner C, Kurtz A, Broeker KA.
    Am J Physiol Renal Physiol; 2022 Mar 01; 322(3):F295-F307. PubMed ID: 35037469
    [Abstract] [Full Text] [Related]

  • 16. Endogenous prostaglandin E2 amplifies IL-33 production by macrophages through an E prostanoid (EP)2/EP4-cAMP-EPAC-dependent pathway.
    Samuchiwal SK, Balestrieri B, Raff H, Boyce JA.
    J Biol Chem; 2017 May 19; 292(20):8195-8206. PubMed ID: 28341741
    [Abstract] [Full Text] [Related]

  • 17. The cyclooxygenase-2-prostaglandin E2 pathway maintains senescence of chronic obstructive pulmonary disease fibroblasts.
    Dagouassat M, Gagliolo JM, Chrusciel S, Bourin MC, Duprez C, Caramelle P, Boyer L, Hue S, Stern JB, Validire P, Longrois D, Norel X, Dubois-Randé JL, Le Gouvello S, Adnot S, Boczkowski J.
    Am J Respir Crit Care Med; 2013 Apr 01; 187(7):703-14. PubMed ID: 23328527
    [Abstract] [Full Text] [Related]

  • 18. Prostaglandin E2 Inhibits NLRP3 Inflammasome Activation through EP4 Receptor and Intracellular Cyclic AMP in Human Macrophages.
    Sokolowska M, Chen LY, Liu Y, Martinez-Anton A, Qi HY, Logun C, Alsaaty S, Park YH, Kastner DL, Chae JJ, Shelhamer JH.
    J Immunol; 2015 Jun 01; 194(11):5472-5487. PubMed ID: 25917098
    [Abstract] [Full Text] [Related]

  • 19. Prostaglandin E2 activates the mTORC1 pathway through an EP4/cAMP/PKA- and EP1/Ca2+-mediated mechanism in the human pancreatic carcinoma cell line PANC-1.
    Chang HH, Young SH, Sinnett-Smith J, Chou CE, Moro A, Hertzer KM, Hines OJ, Rozengurt E, Eibl G.
    Am J Physiol Cell Physiol; 2015 Nov 15; 309(10):C639-49. PubMed ID: 26310818
    [Abstract] [Full Text] [Related]

  • 20. Role of prostaglandin E2 receptors in migration of murine and human breast cancer cells.
    Timoshenko AV, Xu G, Chakrabarti S, Lala PK, Chakraborty C.
    Exp Cell Res; 2003 Oct 01; 289(2):265-74. PubMed ID: 14499627
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 27.